SureScreen Diagnostics (Australia)

SureScreen Diagnostics is an award-winning business providing quality rapid diagnostic equipment and services across the globe. As pioneers in lateral flow technology, we are committed to advancing public health through early, accurate detection—enabling timely intervention, reducing risk, and improving outcomes across clinical, workplace, and public safety environments. We offer tailored diagnostic solutions and services across the UK, Europe, and Australia, delivering highly accurate results that consistently meet and exceed customer expectations—always at a fair price. Our state-of-the-art operational site in the UK facilitates the rapid design, production, and distribution of bespoke products and services throughout Europe and the Rest of the World. With a global reach and local responsiveness, SureScreen continues to set new standards in diagnostic innovation. We provide a full spectrum of services, including: Comprehensive laboratory services for reliable health and drug screening. Expert consultation on screening policy, from refining current protocols to building new frameworks. Every organisation is different—so our solutions are tailored to your specific industry, workforce needs, and operational environment. With thousands of satisfied clients across healthcare, law enforcement, education, and corporate sectors, we bring experience, flexibility, and proven outcomes to every engagement. SureScreen’s ongoing investment in research and development has led to cutting-edge innovations, including the world’s first biodegradable lateral flow tests, a rapid test for Mpox, and the first dual Influenza + COVID-19 test approved for use in the UK. From point-of-care diagnostics to workplace safety initiatives, SureScreen Diagnostics delivers the insight and reliability needed to act early protecting health, enhancing performance, and giving you peace of mind.